NOS2 and Parkinson disease: We previously showed that pioglitazone, a PPAR-γ agonist, provided neuroprotective properties to SN dopaminergic neurons in LPS-induced PD models both in vivo and in vitro [10,48], in which pioglitazone prevented LPS-induced expression of iNOS.